Midatech Pharma Plc
(NASDAQ : MTP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
LLYEli Lilly & Co. -0.10%370.721.1%$1217.48m
JNJJohnson & Johnson 0.27%178.480.7%$1163.21m
MRKMerck & Co., Inc. -0.49%109.580.7%$1036.11m
PFEPfizer Inc. 1.56%50.910.9%$1004.39m
ABBVAbbVie, Inc. 0.26%161.601.9%$870.50m
BMYBristol-Myers Squibb Co. 1.12%81.181.1%$769.12m
AZNAstraZeneca Plc 0.90%68.581.0%$364.05m
HZNPHorizon Therapeutics Plc 0.26%100.555.4%$306.90m
IDXXIDEXX Laboratories, Inc. 2.52%436.583.9%$237.42m
CTLTCatalent, Inc. 3.57%51.921.9%$230.70m
GSKGSK Plc 1.45%35.090.3%$196.84m
NVSNovartis AG 0.27%89.800.2%$189.47m
NVONovo Nordisk A/S 1.25%126.160.1%$174.90m
ALNYAlnylam Pharmaceuticals, Inc. 0.05%220.708.0%$162.21m
RGENRepligen Corp. 4.95%187.696.7%$140.56m

Company Profile

Midatech Pharma Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.